A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia
Nitin Jain, William Wierda, Alessandra Ferrajoli, Franklin Wong, Susan Lerner, Michael Keating, Susan O'BrienVolume:
115
Year:
2009
Language:
english
Pages:
7
DOI:
10.1002/cncr.24522
File:
PDF, 118 KB
english, 2009